<> Neuland Laboratories Share Price Today: Live Neuland Laboratories Share Price NSE/BSE | 5paisa
NEULANDLAB

Neuland Laboratories Share PriceNeuland Laboratories

₹1420.15
21.4 (1.53%)
As on 05 February, 2023 | 19:27 BSE: 524558 NSE: NEULANDLAB

Neuland Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Neuland Laboratories

Start SIP

Neuland Laboratories Share Price

  • Over 1 Month -17.15%
  • Over 3 Month -3.51%
  • Over 6 Month 21.66%
  • Over 1 Year 9.46%

Neuland Laboratories Key Statistics

P/E Ratio 22
PEG Ratio 1.6
Market Cap Cr 1,822
Price to Book Ratio 2.2
EPS 50.6
Dividend 0.4
Relative Strength Index 33.64
Money Flow Index 13.16
MACD Signal -52.47
Average True Range 77.43

Neuland Laboratories Investment Rating

  • Master Rating:
  • Neuland Laboratories has an operating revenue of Rs. 1,007.22 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 9% is okay, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 12%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 64 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Neuland Laboratories Financials
IndicatorSep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 294221256
Operating Expenses Qtr Cr 225193217
Operating Profit Qtr Cr 692839
Depreciation Qtr Cr 131312
Interest Qtr Cr 333
Tax Qtr Cr 1532
Net Profit Qtr Cr 381022

Neuland Laboratories Technicals

EMA & SMA

Current Price
₹1420.15
21.4 (1.53%)
  • Bullish Moving Average
  • ___
  • 1
  • Bearish Moving Average
  • ___
  • 15
  • 20 Day
  • 1539.75
  • 50 Day
  • 1593.09
  • 100 Day
  • 1550.2
  • 200 Day
  • 1481.17
  • 20 Day
  • 1575.13
  • 50 Day
  • 1646.33
  • 100 Day
  • 1574
  • 200 Day
  • 1373.88

Neuland Laboratories Resistance and Support

PIVOT
₹1388.62
Resistance
First Resistance 1459.14
Second Resistance 1519.52
Third Resistance 1590.04
RSI 33.64
MFI 13.16
MACD Single Line -52.47
MACD -69.8
Support
First Resistance 1328.24
Second Resistance 1257.72
Third Resistance 1197.34

Neuland Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 33,771 1,454,179 43.06
Week 35,110 1,465,149 41.73
1 Month 28,842 1,424,781 49.4
6 Month 63,245 2,203,443 34.84

Neuland Laboratories Result Highlights

Neuland Laboratories Synopsis

NSE-Medical-Diversified

Neuland Laborat is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 951.08 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2022. Neuland Laboratories Ltd. is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393.
Market Cap 1,835
Sales 1,007
Shares in Float 0.82
No of funds 56
Yield 0.35
Book Value 2.21
U/D Vol ratio 0.9
LTDebt / Equity 12
Alpha 0.13
Beta 0.74

Neuland Laboratories

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 36.14%36.22%36.22%
Mutual Funds 0.79%0.79%0.79%
Foreign Portfolio Investors 17.7%17.68%17.37%
Financial Institutions/ Banks
Individual Investors 30.09%31.02%33.25%
Others 15.28%14.29%12.37%

Neuland Laboratories Management

Name Designation
Dr. Davuluri Rama Mohan Rao Executive Chairman
Mr. Davuluri Sucheth Rao Vice Chairman & CEO
Mr. Davuluri Saharsh Rao Vice Chairman & Mng.Director
Dr. Christopher M Cimarusti Non Executive Director
Mr. Humayun Dhanrajgir Ind. Non-Executive Director
Mrs. Bharati Rao Ind. Non-Executive Director
Dr. Nirmala Murthy Ind. Non-Executive Director
Mr. Parampally Vasudeva Maiya Ind. Non-Executive Director
Mr. Homi Rustum Khusrokhan Ind. Non-Executive Director

Neuland Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Neuland Laboratories Corporate Action

Date Purpose Remarks
2023-02-13 Quarterly Results
2022-11-10 Quarterly Results
2022-08-03 Quarterly Results
2022-05-10 Audited Results & Final Dividend
2022-02-01 Quarterly Results
Date Purpose Remarks
2022-07-15 FINAL Rs.5.00 per share(50%)Final Dividend

Neuland Laboratories MF Shareholding

Name Amount(cr)
Quant Small Cap Fund Growth 2870
Motilal Oswal S&P BSE Healthcare ETF 6

Neuland Laboratories FAQs

What is Share Price of Neuland Laboratories ?

Neuland Laboratories share price is ₹1420 As on 05 February, 2023 | 19:13

What is the Market Cap of Neuland Laboratories ?

The Market Cap of Neuland Laboratories is ₹1822 Cr As on 05 February, 2023 | 19:13

What is the P/E ratio of Neuland Laboratories ?

The P/E ratio of Neuland Laboratories is 22 As on 05 February, 2023 | 19:13

What is the PB ratio of Neuland Laboratories ?

The PB ratio of Neuland Laboratories is 2.2 As on 05 February, 2023 | 19:13

Q2FY23